{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:57:50Z","timestamp":1774529870155,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1053\/j.ajkd.2011.12.034","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T21:53:45Z","timestamp":1332539625000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan"],"prefix":"10.1053","volume":"60","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib1","first-page":"e1","article-title":"USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"57","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2-3","key":"10.1053\/j.ajkd.2011.12.034_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10754-007-9017-8","article-title":"The organization and financing of end-stage renal disease treatment in Japan","volume":"7","author":"Fukuhara","year":"2007","journal-title":"Int J Health Care Finance Econ"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Dr\u00fceke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2011.12.034_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.5001594","article-title":"Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease","volume":"102","author":"Fukagawa","year":"2006","journal-title":"Kidney Int Suppl"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.034_bib5","first-page":"S28","article-title":"Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in Japan","volume":"13","author":"Komaba","year":"2009","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.034_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib9","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS Waves 1, 3, and 4 Study","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.034_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","article-title":"Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study","volume":"11","author":"Kimata","year":"2007","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1744-9987.2007.00540.x","article-title":"Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan","volume":"12","author":"Nakai","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archsurg.1995.01430050088015","article-title":"Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients","volume":"130","author":"Punch","year":"1995","journal-title":"Arch Surg"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.034_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0272-6386(99)70305-7","article-title":"Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure","volume":"33","author":"Stracke","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1072-7515(99)00212-4","article-title":"A study on pruritus after parathyroidectomy for secondary hyperparathyroidism","volume":"190","author":"Chou","year":"2000","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.034_bib17","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1053\/ajkd.2001.27432","article-title":"More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism","volume":"38","author":"Tominaga","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib18","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.034_bib19","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1053\/j.ajkd.2011.12.034_bib20","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.034_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1744-9987.2008.00556.x","article-title":"Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"12","author":"Akiba","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.034_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156717","article-title":"Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"29","author":"Shigematsu","year":"2009","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.034_bib25","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","article-title":"Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis","volume":"49","author":"Narayan","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.034_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2215\/CJN.06141108","article-title":"Simultaneous control of PTH and CaxP is sustained over three years of treatment with cinacalcet HCl","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2011.12.034_bib28","article-title":"Economic Evaluation in Health Care: Merging Theory With Practice","author":"Drummond","year":"2001","journal-title":"New York, NY: Oxford University Press"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1744-9987.2010.00893.x","article-title":"Overview of regular dialysis treatment in Japan (as of 31 December 2008)","volume":"14","author":"Nakai","year":"2010","journal-title":"Ther Apher Dial"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.034_bib30","first-page":"361","article-title":"Bone metabolism and risk of death and cardiovascular disease (CVD) in uremic patients: a prospective cohort study in Japan","volume":"22","author":"Taniguchi","year":"2009","journal-title":"Kidney Metab Bone Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.034_bib31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4009\/jsdt.35.1155","article-title":"The current state of chronic dialysis treatment in Japan","volume":"35","author":"Nakai","year":"2002","journal-title":"J Jpn Soc Dial Ther"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.034_bib32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2011.12.034_bib35","first-page":"iii65","article-title":"Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients","volume":"18","author":"Tominaga","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2011.12.034_bib36","series-title":"National Health Insurance Price List [in Japanese]","year":"2010"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000327654","article-title":"Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D","volume":"33","author":"Fukagawa","year":"2011","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.034_bib38","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2215\/CJN.11501210","article-title":"Decreases in PTH in hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns in the MBD-5D Study","volume":"6","author":"Akizawa","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2011.12.034_bib39","series-title":"DPC tennsuu hayami-hyo [Diagnostic Procedure Combination fee schedule in Japan]","year":"2010"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.034_bib40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1291\/hypres.31.1373","article-title":"Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model","volume":"31","author":"Saito","year":"2008","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.034_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.healthpol.2008.12.006","article-title":"Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan","volume":"91","author":"Kondo","year":"2009","journal-title":"Health Policy"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib42","first-page":"49","article-title":"Cost of dialysis treatment in Japan: Eleventh Annual Report of the Japanese Association of Dialysis Physicians, 2007 [in Japanese]","volume":"23","author":"Sugisaki","year":"2008","journal-title":"J Jpn Assoc Dial Physicians"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1046\/j.1523-1755.2003.00289.x","article-title":"Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study","volume":"64","author":"Fukuhara","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib44","first-page":"1","article-title":"The direct medical costs and the quality of life in patients with artificial dialysis and type 2 diabetes [in Japanese]","volume":"50","author":"Inada","year":"2007","journal-title":"J Japan Diabetic Soc"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.034_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1524-4733.2008.00428.x","article-title":"Predicting the Short Form-6D preference-based index using the eight mean Short Form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available","volume":"12","author":"Ara","year":"2009","journal-title":"Value Health"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib46","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ndt\/gfl774","article-title":"The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective","volume":"22","author":"Garside","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"15","key":"10.1053\/j.ajkd.2011.12.034_bib47","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jama.288.15.1851","article-title":"Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-CT-segment elevation myocardial infarction","volume":"288","author":"Mahoney","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11136-004-3928-3","article-title":"Responsiveness of generic health-related quality of life measures in stroke","volume":"14","author":"Pickard","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1053\/j.ajkd.2011.12.034_bib49","series-title":"Economic Estimation of Healthcare Service by Disease Management, Report on Research on Health Services 2000 [in Japanese]","first-page":"91","article-title":"Estimation of the quality of the life in patients with diabetes","author":"Hisashige","year":"2000"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib50","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00198-008-0761-5","article-title":"Sequential change in quality of life for patients with incident clinical fractures: a prospective study","volume":"20","author":"Hagino","year":"2009","journal-title":"Osteoporos Int"},{"issue":"18","key":"10.1053\/j.ajkd.2011.12.034_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11180","article-title":"The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation","volume":"11","author":"Garside","year":"2007","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.034_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1053\/j.ajkd.2011.12.034_bib53","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.034_bib54","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.2010.167","article-title":"Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients","volume":"78","author":"Block","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.034_bib56","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.034_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA Study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib58","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE Study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib59","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1053\/j.ajkd.2010.07.012","article-title":"Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients","volume":"56","author":"Shireman","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.034_bib60","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","article-title":"Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Goodkin","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.034_bib61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.034_bib62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hec.790","article-title":"Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care","volume":"12","author":"Manns","year":"2003","journal-title":"Health Econ"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612004623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612004623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:58:08Z","timestamp":1759456688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612004623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0272638612004623"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.034","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}